<DOC>
	<DOC>NCT01876316</DOC>
	<brief_summary>The Effect of Ethnic on Moxifloxacin Induced QT Interval Prolongation in Korean and Japanese Healthy Subjects</brief_summary>
	<brief_title>The Effect of Ethnic on Moxifloxacin Induced QT Interval Prolongation in Korean and Japanese Healthy Subjects</brief_title>
	<detailed_description>The purpose of this study is to explore the ethnic and gender difference in the Moxifloxacin induced QT interval prolongation between Japanese and Korean subjects.</detailed_description>
	<mesh_term>Moxifloxacin</mesh_term>
	<mesh_term>Fluoroquinolones</mesh_term>
	<mesh_term>Norgestimate, ethinyl estradiol drug combination</mesh_term>
	<criteria>1) Subjects in Japan and Korea deemed healthy as determined by no clinically significant deviation from normal in medical history, physical examination, ECGs, or clinical laboratory determinations. 2) Body Mass Index (BMI) of 17.6 to 26.4 kg/m2, BMI = weight (kg)/ [height (m)]2. 1) Evidence of organ dysfunction or any clinically significant deviation from normal in physical examination, vital signs, ECG or clinical laboratory determinations beyond what is consistent with the target population. 2) Any of the following on 12lead ECG prior to study drug administration, confirmed by repeat. Heart rate ≤ 45 bpmmsec or Heart rate ≥ 100 bpmmsec PR ≥ 210 msec QRS ≥ 120 msec QT ≥ 500 msec QTcF: male ≥ 450 msec, female ≥470msec Iincomplete right bundle branch block Marked Sinus Arrhythmia Wondering pacemaker Atrial rhythm</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>June 2013</verification_date>
	<keyword>Moxifloxacin</keyword>
	<keyword>QT interval prolongation</keyword>
	<keyword>Korean</keyword>
	<keyword>Japanese</keyword>
</DOC>